Real-world effectiveness and tolerability of small-cell lung cancer (SCLC) treatments: A systematic literature review (SLR)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world effectiveness and tolerability of small-cell lung cancer (SCLC) treatments: A systematic literature review (SLR)

Published:2019-07-18 Issue:7 Volume:14 Page:e0219622
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Povsic Manca^ORCID,Enstone Ashley,Wyn Robin,Kornalska Klaudia,Penrod John R.,Yuan Yong

Funder

Bristol-Myers Squibb

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference76 articles.

1. Advances in Small Cell Lung Cancer;GP Kalemkerian;Hematol Oncol Clin North Am,2017

2. Relapsed small cell lung cancer: treatment options and latest developments;N Asai;Ther Adv Med Oncol,2014

3. Small Cell Lung Cancer Stages;Small Cell Lung Cancer Stages,2017

4. Small-cell lung cancer;JP Van Meerbeeck;Lancet,2011

5. Staging and imaging of small cell lung cancer;GP Kalemkerian;Cancer Imaging,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study;Lung Cancer;2024-07

2. Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive‐stage small cell lung cancer (ES‐SCLC): Study protocol;Thoracic Cancer;2024-03

3. Moxibustion for chemotherapy-induced myelosuppression: A systematic review and meta-analysis;European Journal of Integrative Medicine;2023-10

4. Efficacy and safety of fluzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: a multi-center, single-arm prospective phase II clinical study (STAMP study);BMC Cancer;2023-08-14

5. Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy;Advances in Therapy;2023-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3